💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits: lawyer

Published 02/04/2019, 10:33 PM
© Reuters. FILE PHOTO: FILE PHOTO: A Johnson & Johnson building is shown in Irvine
JNJ
-

By Tina Bellon

(Reuters) - Johnson & Johnson's DePuy Orthopaedics unit is in settlement talks to resolve the bulk of individual lawsuits alleging the company's metal-on-metal Pinnacle hip implants were defective and caused severe injuries, a lawyer for the plaintiffs said on Monday.

Texas-based plaintiff lawyer Mark Lanier said lawyers for the consumers had talked to the company in recent days to reach an agreement to resolve the long-running litigation that includes more than 10,000 cases.

"It's still not a done deal, but we're getting close," Lanier said, adding that plaintiffs hope to reach a final agreement by the end of the year.

Lanier said it was uncertain at this point how many of the roughly 10,000 Pinnacle lawsuits would be subject to the settlement. He declined further comment.

A spokeswoman for DePuy on Monday declined to comment.

Bloomberg first reported on the settlement talks.

In 2013, DePuy ceased selling the metal-on-metal Pinnacle devices after the U.S. Food and Drug Administration strengthened its artificial hip regulations. The Pinnacle system continues to be sold with other material combinations.

Metal-on-metal hip implants have come under scrutiny over allegations that the products cause a build-up of metal ions in the blood, causing groin pain, allergic reactions, bone erosion and tissue death.

J&J (NYSE:JNJ) denies those allegations, saying the company acted appropriately and responsibly in the development, testing and marketing of the devices.

Last month, J&J agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over metal-on-metal hip implants. DePuy said the settlement involved no admission of liability or misconduct on the part of the companies.

J&J to date has faced several federal jury trials over the Pinnacle hip implants. It won the first case in 2014, but lost all subsequent trials, with verdicts ranging from $151 million to $540 million.

J&J has appealed those verdicts.

© Reuters. FILE PHOTO: FILE PHOTO: A Johnson & Johnson building is shown in Irvine

News of the settlement talks on Monday caused a federal judge overseeing an ongoing Pinnacle trial in Dallas to dismiss the jury in that case. Lanier said that case, involving five Texas plaintiffs, has not been settled yet.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.